SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-21-003855
Filing Date
2021-08-11
Accepted
2021-08-11 16:56:58
Documents
2
Period of Report
2021-08-09

Document Format Files

Seq Description Document Type Size
1 form3-08112021_010825.html 3  
1 form3-08112021_010825.xml 3 1658
2 ex24-08112021_010828.htm EX-24 8160
  Complete submission text file 0001415889-21-003855.txt   11313
Mailing Address ONE MAIN STREET, 10TH FLOOR CAMBRIDGE MA 02142
Business Address ONE MAIN STREET, 10TH FLOOR CAMBRIDGE MA 02142 617-417-5868
Black Diamond Therapeutics, Inc. (Issuer) CIK: 0001701541 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 79 TW ALEXANDER DRIVE 4501 RESEARCH COMMONS, SUITE 100 RESEARCH TRIANGLE PARK NC 27709
Business Address
Velleca Mark A. (Reporting) CIK: 0001706847 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39200 | Film No.: 211164305